taurocholic acid has been researched along with vorinostat in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, Y; Choi, HW; Chung, SW; Kim, CW; Kim, JY; Kim, K; Kim, S; Kim, SY; Kwon, IC; Oh, YK; Park, J; Shim, G; Yang, VC | 1 |
1 other study(ies) available for taurocholic acid and vorinostat
| Article | Year |
|---|---|
Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex.
Topics: Animals; Antineoplastic Agents; Cations; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Electrophoretic Mobility Shift Assay; Heparin; Hydroxamic Acids; Injections, Intravenous; Liposomes; Mice; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Serum; Taurocholic Acid; Time Factors; Tissue Distribution; Vorinostat | 2012 |